JPH03167113A - Hair regenerating agent - Google Patents
Hair regenerating agentInfo
- Publication number
- JPH03167113A JPH03167113A JP1305936A JP30593689A JPH03167113A JP H03167113 A JPH03167113 A JP H03167113A JP 1305936 A JP1305936 A JP 1305936A JP 30593689 A JP30593689 A JP 30593689A JP H03167113 A JPH03167113 A JP H03167113A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- adenosine
- hair growth
- effect
- cyclic monophosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 48
- 230000001172 regenerating effect Effects 0.000 title abstract 4
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 claims abstract description 22
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 claims abstract description 21
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000002207 metabolite Substances 0.000 claims abstract description 14
- 229940109850 royal jelly Drugs 0.000 claims abstract description 14
- 229940107700 pyruvic acid Drugs 0.000 claims abstract description 8
- 230000001256 tonic effect Effects 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 7
- 239000012676 herbal extract Substances 0.000 claims description 6
- 230000003779 hair growth Effects 0.000 abstract description 54
- 239000003795 chemical substances by application Substances 0.000 abstract description 27
- 239000000284 extract Substances 0.000 abstract description 24
- 230000001737 promoting effect Effects 0.000 abstract description 16
- 201000004384 Alopecia Diseases 0.000 abstract description 10
- 230000004151 fermentation Effects 0.000 abstract description 9
- 238000000855 fermentation Methods 0.000 abstract description 9
- 239000012138 yeast extract Substances 0.000 abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000654 additive Substances 0.000 abstract description 4
- 229940041514 candida albicans extract Drugs 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 230000007794 irritation Effects 0.000 abstract description 3
- 150000001298 alcohols Chemical class 0.000 abstract description 2
- 230000001186 cumulative effect Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 231100000360 alopecia Toxicity 0.000 abstract 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000000384 rearing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 53
- 229920002527 Glycogen Polymers 0.000 description 14
- 229940096919 glycogen Drugs 0.000 description 14
- 239000000126 substance Substances 0.000 description 11
- 230000003676 hair loss Effects 0.000 description 9
- 208000024963 hair loss Diseases 0.000 description 9
- 230000004060 metabolic process Effects 0.000 description 9
- 235000015961 tonic Nutrition 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 229940076788 pyruvate Drugs 0.000 description 7
- 230000003658 preventing hair loss Effects 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- -1 cyclic monophosphate Chemical class 0.000 description 5
- 210000004761 scalp Anatomy 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 244000184734 Pyrus japonica Species 0.000 description 4
- 230000032823 cell division Effects 0.000 description 4
- 230000003780 keratinization Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 230000003662 hair growth rate Effects 0.000 description 3
- 230000037353 metabolic pathway Effects 0.000 description 3
- 229960000716 tonics Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000034659 glycolysis Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- IZLVFLOBTPURLP-UHFFFAOYSA-N 2-Methoxy-4-nitrophenol Chemical compound COC1=CC([N+]([O-])=O)=CC=C1O IZLVFLOBTPURLP-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229960004424 carbon dioxide Drugs 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-M pentadecanoate Chemical compound CCCCCCCCCCCCCCC([O-])=O WQEPLUUGTLDZJY-UHFFFAOYSA-M 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、新規な養毛剤に関する。さらに詳しくは、発
毛、育毛を促進し、脱毛を防止し得る養毛効果の優れた
養毛剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a novel hair nourishing agent. More specifically, the present invention relates to a hair nourishing agent with excellent hair nourishing effects that can promote hair growth and growth and prevent hair loss.
従来から、脱毛、発毛のメカニズムについては、種々の
提案がなされているが、いまだ確立した説はない、それ
らの諸説を集約すると、大部分のものは、頭皮の血行を
促進して毛母細胞の働きを活発にすることが、発毛、育
毛を促進する要因であると考えられているようである。Various proposals have been made regarding the mechanisms of hair loss and hair growth, but no established theory has been established.The majority of these theories promote blood circulation in the scalp and stimulate the growth of hair follicles. It seems that activating cell function is a factor that promotes hair growth and hair growth.
また、毛乳頭にエネルギーを付与することが発毛を促進
するという説もある。There is also a theory that providing energy to the dermal papilla promotes hair growth.
そして、それらそれぞれの説にしたがって血行を促進す
る物質を有効成分として加えた養毛剤(たとえば、特開
昭62−145007号公報、特開昭59−13744
8号公報、特開昭60−16925号公報、特開昭62
−4215号公報、特開昭60−136589号公報)
や毛乳頭にエネルギーを付与する物質を有効成分として
加えた養毛剤(たとえば、特開昭60−116620号
公報、特開昭58−85808号公報、特開昭60−1
16616号公報、特開昭61−152613号公報)
が提案されている。According to each of these theories, hair tonics containing substances that promote blood circulation as active ingredients (for example, JP-A-62-145007, JP-A-59-13744)
Publication No. 8, JP-A-60-16925, JP-A-62
-4215 Publication, Japanese Patent Application Laid-Open No. 60-136589)
Hair tonics containing substances that impart energy to hair and dermal papilla as an active ingredient (for example, JP-A-60-116620, JP-A-58-85808, JP-A-60-1)
16616, JP-A-61-152613)
is proposed.
しかしながら、脱毛や発毛のメカニズムは非常に複雑で
あって、単に頭皮の血行を促進したり、毛乳頭にエネル
ギーを付与するだけでは、脱毛を充分に防止し、発毛、
育毛を充分に促進することはできない。However, the mechanisms of hair loss and hair growth are extremely complex, and simply promoting blood circulation in the scalp or providing energy to the dermal papilla cannot sufficiently prevent hair loss, promote hair growth,
Hair growth cannot be sufficiently promoted.
したがって、より養毛効果の優れた養毛剤、すなわち、
より一層、発毛、育毛を促進し、脱毛を効果的に防止し
得る養毛剤の出現が望まれている。Therefore, a hair nourishing agent with better hair nourishing effect, namely,
The emergence of a hair tonic that can further promote hair growth and hair growth and effectively prevent hair loss is desired.
本発明者は、上記の事情に鑑み、養毛効果の優れた養毛
剤を開発するため種々研究を重ねた結果、アデノシン−
3′,5′−サイクリックモノホスフェートが発毛、育
毛を促進し、脱毛を効果的に防止すること、ならびにピ
ルビン酸や発酵代謝物がアデノシン−3′,5′ −サ
イクリックモノホスフェートの発毛、育毛作用や脱毛防
止作用などの養毛作用を助長し、かつ、これらにさらに
セファランチン、ローヤルゼリーおよび薬草抽出エキス
を添加するときは、アデノシン−3′,5′ −サイク
リックモノホスフェートの養毛作用がさらに向上して、
養毛効果の優れた養毛剤が得られることを見出し、本発
明を完成するにいたった。In view of the above circumstances, the present inventor has conducted various researches in order to develop a hair nourishing agent with excellent hair nourishing effects, and has found that adenosine
3',5'-cyclic monophosphate promotes hair growth and hair growth and effectively prevents hair loss, and pyruvate and fermentation metabolites promote the production of adenosine-3',5'-cyclic monophosphate. Adenosine-3',5'-cyclic monophosphate's hair-nourishing effect promotes hair-nourishing effects such as hair growth and hair loss prevention effects, and when cephalanthine, royal jelly, and medicinal herb extracts are added to these. The effect is further improved,
It was discovered that a hair nourishing agent with excellent hair nourishing effects can be obtained, and the present invention was completed.
すなわち、本発明は、アデノシン−3′,5′サイクリ
ツクモノホスフエートと、ピルビン酸と、発酵代謝物と
、セファランチンと、ローヤルゼリーと、薬草抽出エキ
スを有効成分として含有することを特徴とする養毛剤に
関する。That is, the present invention provides a hair growth agent containing adenosine-3',5' cyclic monophosphate, pyruvic acid, fermented metabolites, cephalanthine, royal jelly, and medicinal herbal extract as active ingredients. Regarding.
本発明において有効成分として用いるアデノシン−3′
,5′−サイクリックモノホスフェートは、英文名で示
すと、Adenosine−3’ +5’ cycl
ic■onophosphateであって、その化学構
造式は次のとおりである。Adenosine-3' used as an active ingredient in the present invention
, 5'-cyclic monophosphate is expressed in English as Adenosine-3'+5' cycl
ic■onophosphate, and its chemical structural formula is as follows.
H
また、ピルビン酸は、化学構造式CH,C0C00Hで
示され、生体内物質代謝経路における重要中間体として
知られた物質である。H Pyruvic acid is represented by the chemical structural formula CH, C0C00H, and is a substance known as an important intermediate in the metabolic pathway of substances in living organisms.
そして、本発明において用いる発酵代謝物とは、酵母エ
キス、ビフィズスエキスなどであり、酵母エキスは、パ
ン酵母の自己消化濃縮によりビタミン類、ヌクレオタイ
ド(酵母本来の物質)を破壊しないで取り出したエキス
であり、ビタミンBを多種多用に含んでいて、後述する
ように、このビタミンBがアデノシン−3′,5′−サ
イクリックモノホスフェートの養毛作用を助長する要因
になるものと考えられる。The fermented metabolites used in the present invention include yeast extract, bifidus extract, etc. Yeast extract is an extract obtained by autolyzing and concentrating baker's yeast without destroying vitamins and nucleotides (substances inherent in yeast). It contains a wide variety of vitamin B, and as described below, this vitamin B is considered to be a factor that promotes the hair-nourishing effect of adenosine-3',5'-cyclic monophosphate.
また、ビフィズスエキスは、ビフィズス菌を培養して得
られるエキスであり、ビフィズム経路由来の物質(酵素
)を含有し、毛質皮膚のエネルギー物質となるアデノシ
ン三リン酸を産生じ、これがアデノシン−3′,5′
−サイクリックモノホスフェートの養毛作用を助長する
要因になるものと考えられる。In addition, bifidus extract is an extract obtained by culturing bifidobacteria, and it contains substances (enzymes) derived from the bifidism pathway, and produces adenosine triphosphate, which is an energy substance for hairy skin. ',5'
- It is thought that this is a factor that promotes the hair-nourishing effect of cyclic monophosphate.
そして、これらの酵母エキスやビフィズスエキスは、そ
れぞれ単独で用いてもよいし、また両者を混合して用い
てもよい。These yeast extracts and bifidus extracts may be used alone or in combination.
セファランチン、ローヤルゼリー、薬草抽出エキスは、
従来からもこの種の用途に用いられてきた物質であるが
、本発明においては、薬草抽出エキスとして、ニンジン
エキス、センブリエキス、クジンエキス、センキエウエ
キス、エンメイソウエキス、オオバクエキスなどが単独
でまたは2種以上混合して用いられる。Cephalanthine, royal jelly, medicinal herb extracts,
Substances have been used for this type of application in the past, but in the present invention, as medicinal herbal extracts, carrot extract, Japanese japonica extract, japonica extract, japonica extract, japonica extract, orientalis extract, etc. are used singly or in combination. It is used by mixing more than one species.
上記のアデノシン−3′,5′ −サイクリックモノホ
スフェートが優れた養毛効果を発揮し、ピルビン酸や発
酵代謝物がそのアデノシン−3′,5′−サイクリック
モノホスフェートの便れた養毛作用を助長し、またセフ
ァランチン、ローヤルゼリー、薬草抽出エキスを添加す
ることによって養毛効果がさらに向上する理由は、現在
のところ必ずしも明確ではないが、次のように考えられ
る。The above-mentioned adenosine-3',5'-cyclic monophosphate exhibits an excellent hair-nourishing effect, and pyruvate and fermentation metabolites of adenosine-3',5'-cyclic monophosphate have an excellent hair-nourishing effect. The reason why the addition of cephalanthine, royal jelly, and medicinal herb extract further improves the hair-nourishing effect is not entirely clear at present, but it is thought to be as follows.
まず、アデノシン−3′,5′−サイクリックモノホス
フェート、ピルビン酸、発酵代謝物について考えてみる
と、毛R111m中にはグリコーゲンが存在し、このグ
リコーゲンの代謝(つまり、グリコーゲンの解糖、ペン
トースサイクルおよびTCAサイクル)が電球の細胞分
裂やケラチン化を起こさせるエネルギーとなり、この電
球の細胞分裂やケラチン化が発毛、育毛を促進し、脱毛
を防止することになるが、上記のアデノシン−3′,5
′−サイクリックモノホスフェートはグリコーゲンの解
糖に関与してグリコーゲンの代謝を促進し、電球の細胞
分裂やケラチン化を起こさせて、発毛、育毛を促し、脱
毛を防止する。First, considering adenosine-3',5'-cyclic monophosphate, pyruvate, and fermentation metabolites, glycogen exists in hair R111m, and the metabolism of this glycogen (that is, glycogen glycolysis, pentose cycle and TCA cycle) provide the energy that causes cell division and keratinization in the bulb, and this cell division and keratinization in the bulb promotes hair growth and hair growth and prevents hair loss, but the adenosine-3 mentioned above ',5
'-Cyclic monophosphate participates in glycogen glycolysis, promotes glycogen metabolism, causes bulb cell division and keratinization, promotes hair growth, and prevents hair loss.
また、アデノシン−3′,5′ −サイクリックモノホ
スフェートは、皮膚組織を再生し、血管ネットワークを
増加させて、頭皮への血流を増加させ、その結果、血液
中から供給されるグリコーゲン量が増大し、解糖系を通
じてエネルギー物質に変換され、毛母細胞を活性化させ
、発毛、育毛を促進し、脱毛を防止する。Adenosine-3',5'-cyclic monophosphate also regenerates skin tissue, increases the blood vessel network, and increases blood flow to the scalp, resulting in an increase in the amount of glycogen supplied from the blood. It increases in size and is converted into energy substances through the glycolytic system, activating hair matrix cells, promoting hair growth and hair growth, and preventing hair loss.
ピルビン酸は、グリコーゲンの代謝経路におけるTCA
サイクルを促進して、アデノシン−3′、5′−サイク
リックモノホスフェートの発毛、育毛作用や脱毛防止作
用を助長する。Pyruvate is a TCA in the glycogen metabolic pathway.
It promotes the hair growth, hair growth and hair loss prevention effects of adenosine-3',5'-cyclic monophosphate.
また、発酵代謝物としての酵母エキスは、前述したよう
に、ビタミンBを多量に含んでいて、そのビタミンBが
グリコーゲンの代謝を促進し、アデノシン−3′,5′
−サイクリックモノホスフェートの養毛作用を助長す
る。In addition, as mentioned above, yeast extract as a fermentation metabolite contains a large amount of vitamin B, which promotes glycogen metabolism and adenosine-3',5'
- Promote the hair-nourishing effect of cyclic monophosphate.
そして、ビフィズスエキスは、ビフイズム経路由来の酵
素を有していて、この酵素がアデノシン三リン酸を産生
じ、このアデノシン三リン酸がグリコーゲンの代謝を促
進して、アデノシン−3′、5′ −サイクリックモノ
ホスフェートの養毛作用を助長する。Bifidus extract contains an enzyme derived from the Bifism pathway, and this enzyme produces adenosine triphosphate, which promotes glycogen metabolism and adenosine-3', 5'- Promotes the hair growth effect of cyclic monophosphate.
本発明においては、これらアデノシン−3′,5′サイ
クリツクモノホスフエート、ピルビン酸、発酵代謝物以
外に、セファランチン、ローヤルゼリーおよび薬草抽出
エキスを添加するが、これらセファランチン、ローヤル
ゼリー、薬草抽出エキスがどのようにしてアデノシン−
3′,5′ −サイクリックモノホスフェートの養毛作
用を向上させるのかは現在のところ明らかでないが、こ
れらセファランチン、ローヤルゼリー、薬草抽出エキス
が下記のような特性を有していて、それがアデノシン−
3′,5′−サイクリックモノホスフェートの養毛効果
を向上させるものと考えられる。In the present invention, in addition to these adenosine-3',5' cyclic monophosphate, pyruvate, and fermented metabolites, cephalanthine, royal jelly, and medicinal herb extracts are added. In this way, adenosine-
It is currently unclear whether 3',5'-cyclic monophosphate improves the hair-nourishing effect, but these cephalanthine, royal jelly, and medicinal herb extracts have the following properties, which are adenosine-
It is thought that this improves the hair-nourishing effect of 3',5'-cyclic monophosphate.
セファランチンは、ツヅラフジ科の植物から抽出したア
ルカロイドであり、次のような作用を有している。Cephalanthine is an alkaloid extracted from a plant belonging to the family Cephalanthiaceae, and has the following effects.
■ 神経、筋肉およびその他の組織の細胞原形質に作用
し、その機能亢進をする。■ Acts on the cell plasma of nerves, muscles, and other tissues, increasing their function.
■ 免疫体産生作用
■ 細網内皮系に及ぼす作用
■ 抗アレルギー作用
■ 毒素中和作用
■ 副交感神経緊張緩解作用
また、ローヤルゼリーは、脱毛原因の一つとして考えら
れている皮脂分泌過剰を正常化する作用を有している。■ Immune production effect ■ Effect on the reticuloendothelial system ■ Anti-allergic effect ■ Toxin neutralization effect ■ Parasympathetic tone-relaxing effect Royal jelly also normalizes excessive sebum secretion, which is thought to be one of the causes of hair loss. It has an effect.
薬草抽出エキスは、従来からも、生薬として知られたも
のであり、各種のビタミンなどを含んでいて、これらが
アデノシン−3′,5′−サイクリックモノホスフェー
トの養毛作用に好影響を及ぼすものと考えられる。Medicinal herb extracts have long been known as herbal medicines and contain various vitamins, which have a positive effect on the hair-nourishing effect of adenosine-3',5'-cyclic monophosphate. considered to be a thing.
このような本発明の養毛剤に対し、従来の養毛剤でも、
血行を促進したり、血流を増加させたりするが、その方
法は血管を拡張したり、頭皮に刺激(温熱、冷却)を与
え、その刺激の反作用で血流量を増加させるものであっ
て、本発明のように継続的にグリコーゲンの代謝を促進
して、電球の細胞分裂やケラチン化を引き起こすことに
より、発毛、育毛作用や脱毛防止作用を生じさせるもの
ではないので、養毛効果の生じる確立が本発明の場合よ
り少ない。In contrast to such a hair tonic of the present invention, even conventional hair tonics,
The method of promoting or increasing blood circulation is to dilate blood vessels or apply stimulation (heating, cooling) to the scalp, and the reaction to that stimulation increases blood flow. Since it does not produce hair growth, hair growth or hair loss prevention effects by continuously promoting glycogen metabolism and causing bulb cell division and keratinization as in the present invention, it does not produce hair growth, hair growth or hair loss prevention effects. The probability is less than in the case of the present invention.
本発明の養毛剤を調製するにあたっては、有効成分であ
るアデノシン−3′,5′−サイクリックモノホスフェ
ートとピルビン酸と発酵代謝物とセファランチンとロー
ヤルゼリーと薬草抽出エキスとを、たとえば水、エタノ
ールなどの低級アルコール類などに溶解すればよいが、
その際に、この種の用途において許容可能な添加剤およ
び薬剤を加えた形で調製してもよい、また、他の剤型に
調製することもできる。In preparing the hair tonic of the present invention, the active ingredients adenosine-3',5'-cyclic monophosphate, pyruvic acid, fermented metabolites, cephalanthine, royal jelly, and medicinal herbal extracts are mixed in water, ethanol, etc. It can be dissolved in lower alcohols, etc.
At that time, it may be prepared with additives and drugs acceptable for this type of use, or it may be prepared in other dosage forms.
上記の添加剤、薬剤としては、血行促進剤、新陳代謝促
進剤、抗男性ホルモン剤、抗炎症剤、抗アレルギー剤、
保湿剤、頭皮への栄養剤、抗菌剤、清涼剤、油分、界面
活性剤、香料、酸化防止剤、紫外線吸収剤、色素、増粘
剤、pH!II整剤、キレート剤などがあげられるが、
これらの添加剤、薬剤の代表的なものを具体的に例示す
ると、たとえば、酢酸トコフェノール、塩化カルプロニ
ウム、ミノキシジル、炭酸ガス、ヒノキチオール、安息
香酸パントニールエチルエーテル、ペンタデカン酸グリ
セリド、ビタミン■1、エチニルエストラジオール、グ
リチルリチン酸、塩酸ジフェニルヒドラミン、ヒアルロ
ン酸、ミニササニシキエキス、モノニトログアヤコール
、トウガラシチンキ、ショウキ町つチンキ、線維芽細胞
活性囚子抽出液、ヒドロコーチシン、塩酸ジフェンヒド
ラミン、溶性シスチン、D−パントテニルアルコール、
サリチル酸、乳酸、乳酸ナトリウム、プラセンターエキ
ス、メントールなどである。The above additives and drugs include blood circulation promoters, metabolism promoters, anti-androgen agents, anti-inflammatory agents, anti-allergy agents,
Moisturizer, nourishing agent for the scalp, antibacterial agent, cooling agent, oil, surfactant, fragrance, antioxidant, ultraviolet absorber, pigment, thickener, pH! Examples include II conditioning agents, chelating agents, etc.
Specific examples of these additives and drugs include tocophenol acetate, carpronium chloride, minoxidil, carbon dioxide, hinokitiol, pantonyl ethyl benzoate, glyceride pentadecanoate, vitamin 1, and ethinyl. Estradiol, glycyrrhizic acid, diphenylhydramine hydrochloride, hyaluronic acid, Minisasanishiki extract, mononitroguaiacol, capsicum tincture, Shokimachitsu tincture, fibroblast activated prisoner extract, hydrocortiscin, diphenhydramine hydrochloride, soluble cystine, D- pantothenyl alcohol,
These include salicylic acid, lactic acid, sodium lactate, placenta extract, and menthol.
上記の養毛剤において、有効成分であるアデノシン−3
′,5′−サイクリックモノホスフェートは0.01〜
5重量%、望ましくは0.01〜0.1重量%含有させ
るのが適当である。つまり、アデノシン−3′,5′
−サイクリックモノホスフェートの養毛剤中での含有量
が0.01重量%より少ない場合は、グリコーゲンの代
謝を促進して発毛、育毛を促進し、脱毛を防止する効果
が充分に発揮されず、また、アデノシン−3′,5′−
サイクリックモノホスフェートの養毛剤中での含有量を
5重量%より多くしても、発毛、育毛を促進する効果の
増加がみられず、またアデノシン−3′,5′−サイク
リックモノホスフェートが多(なることによって循環器
、呼吸器、消化器などへの副作用が生じるおそれがある
からである。In the above hair tonic, the active ingredient adenosine-3
',5'-cyclic monophosphate is 0.01~
It is suitable to contain 5% by weight, preferably 0.01 to 0.1% by weight. In other words, adenosine-3',5'
- If the content of cyclic monophosphate in the hair growth agent is less than 0.01% by weight, the effect of promoting glycogen metabolism, promoting hair growth, and preventing hair loss will not be sufficiently exhibited; Also, adenosine-3',5'-
Even if the content of cyclic monophosphate in a hair growth agent was increased to more than 5% by weight, no increase in the effect of promoting hair growth and hair growth was observed, and adenosine-3',5'-cyclic monophosphate This is because there is a risk of side effects on the circulatory system, respiratory system, digestive system, etc.
また、ピルビン酸は、養毛剤中0.01〜5重量%、望
ましくは0.10〜1.0重量%含有させるのが適当で
ある。つまり、ピルビン酸の含有量が0.01重量%よ
り少ない場合は、グリコーゲンの代謝経路におけるTC
Aを促進させる作用が充分に発揮されず、そのためアデ
ノシン−3′,5′−サイクリックモノホスフェートの
養毛作用を助長する効果が少なくなり、また、ピルビン
酸の含有量を5重量%より多くしても、アデノシン−3
′,5′ −サイクリックモノホスフェートの発毛、育
毛作用などを助長する効果が増加せず、またピルビン酸
の増加によって酸性が強くなりすぎて皮膚のかぶれを生
じるおそれがあるからである。Further, it is appropriate that pyruvic acid be contained in the hair nourishing agent in an amount of 0.01 to 5% by weight, preferably 0.10 to 1.0% by weight. In other words, if the content of pyruvate is less than 0.01% by weight, TC in the glycogen metabolic pathway
The effect of promoting A is not sufficiently exerted, and therefore the effect of promoting the hair-nourishing effect of adenosine-3',5'-cyclic monophosphate is reduced. However, adenosine-3
This is because the effect of promoting hair growth and hair growth of ',5'-cyclic monophosphate is not increased, and the increase in pyruvic acid may make the acidity too strong and cause skin irritation.
そして、発酵代謝物は、養毛剤中0.1〜lO重量%、
望ましくは0.5〜5重景重量有させるのが適当である
。つまり、発酵代謝物の含有量が0.1重量%より少な
い場合は、グリコーゲンの代謝を促進してアデノシン−
3′,5′−サイクリックモノホスフェートの養毛作用
を助長する効果が充分に発揮されず、また、発酵代謝物
の含有量を10重量%より多くしても、アデノシン−3
′,5′ −サイクリックモノホスフェートの養毛作用
を助長する効果が増加しなくなるからである。The fermented metabolites are 0.1 to 10% by weight in the hair nourishing agent.
Preferably, it has a weight of 0.5 to 5. In other words, when the content of fermentation metabolites is less than 0.1% by weight, glycogen metabolism is promoted and adenosine
The effect of 3',5'-cyclic monophosphate in promoting hair growth was not sufficiently demonstrated, and even if the content of fermentation metabolites was increased beyond 10% by weight, adenosine-3
This is because the effect of promoting the hair-nourishing action of the ',5'-cyclic monophosphate does not increase.
また、セファランチンは、養毛剤中0.001〜0゜0
1重量%、望ましくは0.002〜o、oos重量%含
有させるのが適当である。つまり、セファランチンの含
有量が0.001重景重盪り少ない場合は、アデノシン
−3′,5′−サイクリックモノホスフェートの養毛作
用を向上させる効果が少なく、また、セファランチンの
含有量が0,01重量%より多くなると、皮膚のかぶれ
が生じるなどの副作用が生じるおそれがあるからである
。In addition, cephalanthine is present in hair growth products in amounts of 0.001 to 0°0.
It is suitable to contain 1% by weight, preferably 0.002 to 0.00% by weight. In other words, when the content of cephalanthine is less than 0.001, the effect of adenosine-3',5'-cyclic monophosphate on improving the hair growth effect is small; .01% by weight may cause side effects such as skin irritation.
そして、ローヤルゼリーは、養毛剤中0.1〜10重量
%、望ましくは0.2〜2.0重量%含有させるのが適
当である。つまり、ローヤルゼリーの含有量が0.1重
量%より少ない場合は、アデノシン3′,5′ −サイ
クリックモノホスフェートの養毛作用を向上させる効果
が少なくなり、また、ローヤルゼリーの含有量を10重
量%より多くしても、皮脂分泌を正常化する機能の向上
がみられなくなるからである。It is appropriate that royal jelly is contained in the hair nourishing agent in an amount of 0.1 to 10% by weight, preferably 0.2 to 2.0% by weight. In other words, if the royal jelly content is less than 0.1% by weight, the effect of improving the hair-nourishing effect of adenosine 3',5'-cyclic monophosphate will be reduced; This is because even if the amount is increased, no improvement in the function of normalizing sebum secretion will be observed.
また、薬草抽出エキスは、養毛剤中0.06〜6.0重
量%、望ましくは0.3〜1.0重量%含有させるのが
適当である。つまり、薬草抽出エキスの含有量が0.0
6重量%より少ない場合は、グリコーゲンの代謝を促進
してアデノシン−3′,5′−サイクリックモノホスフ
ェートの養毛作用を向上さ・Lる効果が充分に発揮され
ず、また、薬草抽出エキスの含有量を6.0重量%より
多くしても、養毛効果を向上させる効果の増加がみられ
なくなると共に、ベタツキが生じるようになるからであ
る。Further, it is appropriate that the medicinal herb extract be contained in the hair nourishing agent in an amount of 0.06 to 6.0% by weight, preferably 0.3 to 1.0% by weight. In other words, the content of medicinal herb extract is 0.0
If it is less than 6% by weight, the effect of promoting glycogen metabolism and improving the hair-nourishing effect of adenosine-3',5'-cyclic monophosphate will not be fully exhibited, and the medicinal herbal extract will not be effective. This is because even if the content is more than 6.0% by weight, the effect of improving the hair growth effect will not increase and stickiness will occur.
つぎに実施例をあげて本発明の養毛剤の養毛効果を具体
的に説明するが、本発明は実施例のみに限られるもので
はない。Next, the hair growth effect of the hair growth agent of the present invention will be specifically explained with reference to Examples, but the present invention is not limited to the Examples.
実施例1〜3および比較例1
第1表に示す処方により養毛剤を調製した。なお、第1
表中の各成分量は重量%で示す。Examples 1 to 3 and Comparative Example 1 Hair nourishing agents were prepared according to the formulations shown in Table 1. In addition, the first
The amount of each component in the table is shown in weight%.
上記実施例1〜3の養毛剤および比較例1の養毛剤につ
いて、白色マウスに対する養毛効果、人間の頭髪に対す
る養毛効果を調べた。The hair growth agents of Examples 1 to 3 and Comparative Example 1 were examined for their hair growth effects on white mice and on human hair.
(1) マ スに る
白色マウス(雄、6週齢)の肩甲部の毛を電気バリカン
で刈った後、脱毛クリームにより完全に除毛し、翌日よ
り実施例1〜3の養毛剤および比較例1の養毛剤を被試
験部の皮膚に毎日朝夕2回、−匹当たり0.1mj!
(ただし、被試験部の面積は2c■X3cmである)ず
つ塗布した。それぞれの養毛剤に対してマウスは一群1
0匹使用し、養毛効果は、発毛があるか否かを3日経過
毎に観察し、また同様に3日経過毎に毛の長さを測定し
た。その結果をそれぞれ第2表および第3表に示す、た
だし、毛の長さは6日経過以後のものについて示す。(1) After cutting the hair on the shoulder blades of a white mouse (male, 6 weeks old) with electric clippers, the hair was completely removed with hair removal cream, and from the next day, the hair growth agents of Examples 1 to 3 and the comparison were used. Apply the hair restorer of Example 1 to the skin of the test area twice daily in the morning and evening - 0.1 mj per animal!
(However, the area of the test area was 2 cm x 3 cm). One group of mice was used for each hair growth agent.
0 mice were used, and the hair growth effect was determined by observing whether or not there was hair growth every 3 days, and similarly measuring the length of the hair every 3 days. The results are shown in Tables 2 and 3, respectively, with the exception that hair lengths are shown after 6 days.
発毛率に関しては、第2表に示すように、実施例1〜3
の養毛剤では、塗布後3日目に20%の発毛率があった
が、比較例1の養毛剤では、塗布後より122日目なる
まで発毛がなく、本発明の有効成分であるアデノシン−
3′,5′−サイクリックモノホスフェートや、ピルビ
ン酸、発酵代謝物、セファランチン、ローヤルゼリー、
薬草抽出エキスなどの発毛効果が明らかであった。Regarding the hair growth rate, as shown in Table 2, Examples 1 to 3
The hair growth agent of Comparative Example 1 had a hair growth rate of 20% on the 3rd day after application, but the hair growth rate of Comparative Example 1 did not show until 122 days after application.
3',5'-cyclic monophosphate, pyruvate, fermentation metabolites, cephalanthine, royal jelly,
The hair growth effect of medicinal herbal extracts was clear.
また、マウスの毛の長さに関しては、第3表に示すよう
に、実施例1〜3の養毛剤では、比較例1の養毛剤に比
べて顕著な毛の成長促進作用が認められた。Regarding the length of mouse hair, as shown in Table 3, the hair growth promoting effects of the hair growth agents of Examples 1 to 3 were found to be more pronounced than that of the hair growth agent of Comparative Example 1.
なお、30日間の観察結果からは、実施例1〜3の養毛
剤および比較例1の養毛剤とも、塗布によるマウスの異
常行動は認められず、また塗布部位での皮膚の発赤、浮
腫、施皮形成は認められず、皮膚への累積刺激性もない
ものと考えられる。In addition, from the observation results for 30 days, no abnormal behavior was observed in mice due to the application of the hair restorers of Examples 1 to 3 and the hair restorer of Comparative Example 1, and no redness, edema, or skin formation of the skin was observed at the application site. was not observed, and it is considered that there is no cumulative irritation to the skin.
(2) の に る
各実施例ごとに、比較例1と対比しつつ、次の試験を行
った。(2) The following tests were conducted for each of the Examples listed in Section 1, while comparing them with Comparative Example 1.
成年男子10人の左右両びん(賛)を剃毛し、それぞれ
その中の1c11角の部分を被試験部分として、各実施
例の養毛剤を右側のびん、比較例1の養毛剤を左側のび
んと定めて、それぞれの被試験部分に毎日朝夕2回、各
1mlずつ塗布した。効果の判定は、試験開始後lO0
日目、左右のびんの被試験部分の毛髪をそれぞれ根元か
ら20本ずつ剃毛し、右側の毛5120本の長さの平均
値(Y)を左側の毛髪20本の長さの平均値(X)で除
した債を求めて評価した。その結果を第4表に示す。Both the left and right bottles (sample) of 10 adult males were shaved, and a 1c11 square part of each was used as the test area, and the hair tonic of each example was placed in the bottle on the right, and the hair tonic of Comparative Example 1 was placed in the bottle on the left. 1 ml of the solution was applied to each test area twice a day, morning and evening. The effectiveness was determined at lO0 after the start of the test.
On day 1, shave 20 hairs from the roots of the tested parts of the left and right bottles, and change the average length of the 5120 hairs on the right (Y) to the average length of the 20 hairs on the left (Y). The bond was divided by X) and evaluated. The results are shown in Table 4.
第4表
第4表に示すように、実施例1〜3とも、XZY値が1
より大きく、実施例1〜3の養毛剤が毛髪生長促進効果
、すなわち育毛効果を有することが明らかにされた。Table 4 As shown in Table 4, in Examples 1 to 3, the XZY value was 1.
It was revealed that the hair growth agents of Examples 1 to 3 had a greater effect on promoting hair growth, that is, a hair growth effect.
(発明の効果)
以上説明したように、本発明の養毛剤は、優れた養毛効
果を発揮し、また、塗布によるi積刺激性も認められず
、養毛剤としてきわめて価値の高いものであった。(Effects of the Invention) As explained above, the hair nourishing agent of the present invention exhibited excellent hair nourishing effects, and no irritant irritation was observed upon application, making it extremely valuable as a hair nourishing agent.
Claims (1)
フェートと、ピルビン酸と、発酵代謝物と、セファラン
チンと、ローヤルゼリーと、薬草抽出エキスとを有効成
分として含有することを特徴とする養毛剤。(1) A hair tonic containing adenosine-3',5'-cyclic monophosphate, pyruvic acid, fermented metabolites, cephalanthine, royal jelly, and medicinal herbal extract as active ingredients.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1305936A JPH03167113A (en) | 1989-11-24 | 1989-11-24 | Hair regenerating agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1305936A JPH03167113A (en) | 1989-11-24 | 1989-11-24 | Hair regenerating agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH03167113A true JPH03167113A (en) | 1991-07-19 |
Family
ID=17951081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1305936A Pending JPH03167113A (en) | 1989-11-24 | 1989-11-24 | Hair regenerating agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH03167113A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994006402A3 (en) * | 1992-09-17 | 1994-05-11 | Cosmetic or dermatologic composition containing at least one saponine of the ginsenoside type, and its applications particularly to hair care | |
| FR2756181A1 (en) * | 1996-11-26 | 1998-05-29 | Au Mont Beaute | COSMETIC, PHARMACEUTICAL COMPOSITION BASED ON INACTIVE CULTURE OF BIFIDOBACTERIUM BACTERIA, MINT OIL AND AN ACID |
| JP2003192541A (en) * | 2001-12-26 | 2003-07-09 | Pola Chem Ind Inc | Hair growth-promoting agent and skin care preparation for hair growth |
| JP2005200356A (en) * | 2004-01-16 | 2005-07-28 | Kanebo Cosmetics Inc | Hair restoration |
| JP2007063144A (en) * | 2005-08-29 | 2007-03-15 | Taisho Pharmaceut Co Ltd | Liquid composition |
| EP0674505B2 (en) † | 1992-12-18 | 2009-08-12 | Beiersdorf Aktiengesellschaft | Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails |
| EP2255782A1 (en) * | 2009-05-25 | 2010-12-01 | Keune Haircosmetics Manufacturing B.V. | Composition for the prevention or treatment of hair loss, and method of preparation |
-
1989
- 1989-11-24 JP JP1305936A patent/JPH03167113A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994006402A3 (en) * | 1992-09-17 | 1994-05-11 | Cosmetic or dermatologic composition containing at least one saponine of the ginsenoside type, and its applications particularly to hair care | |
| EP0674505B2 (en) † | 1992-12-18 | 2009-08-12 | Beiersdorf Aktiengesellschaft | Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails |
| FR2756181A1 (en) * | 1996-11-26 | 1998-05-29 | Au Mont Beaute | COSMETIC, PHARMACEUTICAL COMPOSITION BASED ON INACTIVE CULTURE OF BIFIDOBACTERIUM BACTERIA, MINT OIL AND AN ACID |
| JP2003192541A (en) * | 2001-12-26 | 2003-07-09 | Pola Chem Ind Inc | Hair growth-promoting agent and skin care preparation for hair growth |
| JP2005200356A (en) * | 2004-01-16 | 2005-07-28 | Kanebo Cosmetics Inc | Hair restoration |
| JP2007063144A (en) * | 2005-08-29 | 2007-03-15 | Taisho Pharmaceut Co Ltd | Liquid composition |
| EP2255782A1 (en) * | 2009-05-25 | 2010-12-01 | Keune Haircosmetics Manufacturing B.V. | Composition for the prevention or treatment of hair loss, and method of preparation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4603192B2 (en) | Hair scalp composition | |
| US5407675A (en) | Method and composition for use on the scalp and eyebrow region of a subject | |
| CN112823778A (en) | Hair care compositions and methods of making the same | |
| JP3321712B2 (en) | Topical hair restorer containing pine extract | |
| JP2007204426A (en) | Hair growth promoter | |
| CN112370393B (en) | Hair washing mousse composition and preparation method and application thereof | |
| JPH07126146A (en) | Sin external preparation | |
| CN115444766B (en) | A kind of two-component shampoo with scalp nourishing effect and preparation method thereof | |
| JP2008088075A (en) | Profilaggrin/filaggrin production promoter, epidermal keratinocyte proliferation promoter, skin care preparation for normalizing epidermis/horny cell layer, profilaggrin/filaggrin production-promoting method and epidermal keratinocyte proliferation-promoting method | |
| JPH03167113A (en) | Hair regenerating agent | |
| JP2006028026A (en) | Hair-growing agent | |
| CN105106042B (en) | A kind of scalp massage breast composition of strong root strengthen the hair | |
| JP2001288046A (en) | Composition for scalp and hair | |
| EP0740930A1 (en) | Blood flow improver and cosmetic | |
| CN114250156A (en) | Yeast culture solution, method for producing the same, external preparation for skin, and skin cosmetic | |
| JPH03167111A (en) | Hair regenerating agent | |
| JP3382148B2 (en) | External preparation for head | |
| JPH11302131A (en) | Cosmetic for scalp and hair | |
| JP3542700B2 (en) | Head composition | |
| JPH03167112A (en) | Hair regenerating agent | |
| JP3496896B2 (en) | Hair restorer and hair cosmetic | |
| CN115554380B (en) | Composition for preventing and treating alopecia by acting on hair follicle tissue and application thereof | |
| JPS6143104A (en) | Hair tonic | |
| JP3497586B2 (en) | Hair restorer and hair cosmetic | |
| HK40045325A (en) | Hair care composition and preparation method therefor |